학술논문

The ATG dose and tlc don't impact on the development of GVHD and viral reactivations in patients undergoing cd34+selected allogeneic hematopoietic cell transplantation
Document Type
Journal
Source
BONE MARROW TRANSPLANTATION; NOV 2022, 57 SUPPL 1, p197-p198, 2p. Supplement: 1
Subject
Language
English
ISSN
14765365